Multiple Shots of the BCG Vaccine Protect Type 1 Diabetics from COVID-19
In a double blind, placebo controlled trial, BCG vaccinated type 1 diabetics had significantly lower rates of infection and illness.
Safe Care CommitmentGet the latest news on COVID-19, the vaccine and care at Mass General.Learn more
Press Release5 Minute ReadJun | 9 | 2021
Jason H. Wasfy, MD, MPhilSocietal disadvantages that were baked in before the pandemic led the pandemic to take a tremendously different toll on specific groups of patients.
BOSTON – A new analysis by researchers at Massachusetts General Hospital (MGH) offers a novel perspective on the disproportionate impact that COVID-19 has had on people of color, low-income populations, and other structurally disadvantaged groups. Their findings, published in a research letter to the Journal of General Internal Medicine, emphasize the urgency of addressing inequities that have been exposed by the coronavirus pandemic.
“At Mass General, we are deeply interested in uncovering disparities and then fixing them,” says cardiologist Jason H. Wasfy, MD, MPhil, lead author of the research letter, director of Outcomes Research at the MGH Heart Center and a medical director of the Massachusetts General Physicians Organization (MGPO). In pursuit of that mission, Wasfy and several MGH colleagues decided to analyze the socioeconomic and demographic characteristics of patients tested for COVID-19 at 14 sites within the Mass General Brigham system from the earliest days of the pandemic until mid-December 2020. Those sites include not only hospitals also but community health centers and urgent care clinics. Combining the results of both inpatient and outpatient testing for COVID-19 distinguished this analysis from most earlier inquiries, which primarily focused on inpatient testing. “That made our sample more representative,” says Wasfy. “It’s a more valid way of looking at the total effect of COVID-19 on all patients.”
Another factor that distinguishes this analysis is its sheer size: It is based on test results from 394,536 patients. Electronic health records were used to compile data regarding each patient’s gender, race and insurance status, as well as where they lived (indicated by ZIP code). Publicly available data for information such as median household income and employment status was then compiled for each ZIP code.
The MGH team’s analysis found that 29,977 patients (7.6% of those tested) had positive results for COVID-19. Males (8.2%) were slightly more likely than females (7.2%) to test positive. Stark contrasts emerged when Wasfy and his colleagues broke down positive cases by race and socioeconomic factors. For example:
“Although our study is innovative in using patient-level data to assess the association between positive COVID tests and socioeconomic and demographic characteristics of individual patients, the results confirm that structural constructs in our society persevere and contribute to health outcomes inequities,” says Marcela del Carmen, MD, who is interim president of the MGPO and senior author of the paper.
Wasfy echoes that sentiment, noting that social phenomena—not biology—have a large influence on who becomes infected with the coronavirus. “Societal disadvantages that were baked in before the pandemic led the pandemic to take a tremendously different toll on specific groups of patients,” he says, noting that these factors (often called social determinants of health) influence the risk for other conditions, such as heart disease and type 2 diabetes. “Our results show how profoundly systemic, structural aspects of society are revealed by assessing the spread of disease.”
Wasfy is an assistant professor of Medicine at Harvard Medical School (HMS). Del Carmen is a professor of obstetrics, gynecology, and reproductive biology at HMS.
This research was funded by the American Heart Association and the Massachusetts General Physicians Organization.
About the Massachusetts General Hospital
Massachusetts General Hospital, founded in 1811, is the original and largest teaching hospital of Harvard Medical School. The Mass General Research Institute conducts the largest hospital-based research program in the nation, with annual research operations of more than $1 billion and comprises more than 9,500 researchers working across more than 30 institutes, centers and departments. In August 2020, Mass General was named #6 in the U.S. News & World Report list of "America’s Best Hospitals."
In a double blind, placebo controlled trial, BCG vaccinated type 1 diabetics had significantly lower rates of infection and illness.
Tool may guide researchers who are striving to improve cancer diagnostic and treatment strategies.
The pandemic was a particularly stressful period for communities that have faced discrimination in this country.
The new agent, called TB-403, was well tolerated and induced stabilization of the disease in some medulloblastoma patients.
Research also provides new mechanistic insights into how this delirium occurs.
Researchers have used artificial intelligence to explore psychological well-being and to provide guidance to help people improve their long-term life satisfaction.